Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Aprazer Healthcare Pvt Ltd
30 tablet
Abacavir, Lamivudine
Keep in cold place
Delivering To:
Overview
Abakast-L is a co-formulation of two antiretroviral agents known as Abacavir and Lamivudine. It is an anti-HIV medicine belonging to the class of Nucleotide analog reverse transcriptase inhibitors. It is used in the treatment of infection caused by HIV (human immunodeficiency virus) namely HIV-1 and HIV-2. The drug is also prescribed often for the treatment of AIDS (acquired immunodeficiency syndrome).
HIV
Abacavir (Abakast-L):- It's an NRTI (nucleoside reverse transcriptase inhibitor) that works against the Human Immunodeficiency Virus Type 1 (HIV-1). It is phosphorylated into active metabolites that compete for viral DNA incorporation. Abacavir functions as a chain terminator of DNA synthesis by competitively inhibiting the HIV reverse transcriptase enzyme.
Lamivudine (Abakast-L):- It is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits viral DNA synthesis in the Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis B (HBV) viruses. When phosphorylated, it can produce active metabolites that compete with viral DNA for inclusion. Lamivudine metabolites impede the action of the HIV reverse transcriptase enzyme by incorporating DNA.
Following are the possible side effects that can occur during your treatment with Abakast-l Abacavir-lamivudine 600/300 Mg Tablet. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.
Abakast-L is administered as an oral-use tablet once daily (specifically, as per the doctor’s prescription). It should not be taken in doses greater or less than the prescribed strength. Take the Abakast-L tablet with a glass of water at the same time every day. Do not skip or overdose. Use effective contraception during antiretroviral therapy.
Alcohol
unsafe
Do not consume alcohol while taking Abakast-l Abacavir-lamivudine 600/300 Mg Tablet
Pregnancy
consult your doctor
Do not take Abakast-l Abacavir-lamivudine 600/300 Mg Tablet without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Do not take Abakast-l Abacavir-lamivudine 600/300 Mg Tablet if you're breastfeeding. Consultation of the doctor is advised.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of Abakast-l Abacavir-lamivudine 600/300 Mg Tablet.
Kidney
precaution
Do not take Abakast-l Abacavir-lamivudine 600/300 Mg Tablet without a doctor's consultation in case of kidney problems.
Liver
precaution
Share your medical history with the doctor in case of liver disease before taking Abakast-l Abacavir-lamivudine 600/300 Mg Tablet.
It is ideally advised to not skip any dose of Abakast-L tablets. However, if such a case happens, make sure to contact your medical practitioner.
Abakast-L is a co-formulation of two antiretroviral agents known as Abacavir and Lamivudine. It is used in the treatment of infection caused by HIV (human immunodeficiency virus).
The common side effects of Abakast-L (Abacavir/Lamivudine) are diarrhea, anxiety, headache, fatigue, weakness, fever, chills, sore throat, insomnia, chest pain, confusion, abnormal dreams, a sensation of spinning, etc.
It is ideally advised to not overdose on Abakast-L tablets. However, if such a case happens, make sure to call a poison helpline or emergency medical center.
In pregnant women, the use of Abakast-L tablets may cause harm to the unborn baby. Consult your medical practitioner for the right advice.
In nursing women, the use of Abakast-L tablets may cause harm to the baby. Consult your medical practitioner for the right advice.
Aprazer Healthcare Pvt Ltd
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.